HLN Profile
Haleon plc is a global leader in consumer healthcare, specializing in the research, development, manufacturing, and distribution of a diverse range of healthcare products. The company's operations extend across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Haleon's product portfolio encompasses a broad spectrum of therapeutic categories, including oral health, pain relief, respiratory health, digestive health, and dietary supplements such as vitamins, minerals, and other wellness products.
The company's extensive brand portfolio features well-known names such as Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, Parodontax, and Centrum. These brands represent Haleon’s commitment to delivering high-quality healthcare solutions that cater to various consumer needs and preferences. By offering products across multiple therapeutic areas, Haleon addresses a wide array of health concerns and supports overall well-being.
Incorporated in 2021, Haleon plc was formerly known as DRVW 2022 plc before adopting its current name in February 2022. The rebranding reflects the company’s strategic focus on expanding its consumer healthcare footprint and strengthening its market position. Headquartered in Brentford, the United Kingdom, Haleon leverages its global presence and extensive distribution network to effectively reach and serve consumers worldwide.
Haleon’s approach to business emphasizes innovation, customer-centricity, and operational excellence. The company invests in cutting-edge research and development to enhance its product offerings and maintain its competitive edge in the dynamic healthcare market. With a strong commitment to sustainability and responsible practices, Haleon is dedicated to advancing consumer health while contributing positively to global health outcomes and community well-being.
|
